论文信息 - Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia - 字舞流文

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

H. de Haard | A. Newland | M. Michel | H. Liebman | H. Haard | D. Kuter | T. Dreier | B. Sánchez‐González | L. Rejtő | M. Egyed | N. Romanyuk | N. Leupin | P. Ulrichts | D. Gandini | K. Verschueren | E. Ward | M. Godar | J. Beauchamp | H. A. Liebman | P. Ulrichts